DECEMBER 20238Medical device companies face an interesting challenge when approaching product innovation. How do they innovate in a truly meaningful way to address the evolving needs of their customers while honoring the legacy and historical success of their signature products? Companies have traditionally involved the customer at some point in product development, however it has tended to be during the final phases of development when testing occurs. What if companies employed a broader approach that made the end user a focal point in all phases of the development process ­ from product ideation to final delivery? LivaNova, a global market leader in heart-lung machines and cardiopulmonary equipment for nearly 50 COMPREHENSIVE, USER-CENTRIC DESIGN: THE FUTURE OF MEDICAL DEVICE INNOVATION Marco Dolci, President Cardiopulmonary & Executive Officer, LivaNova [NASDAQ:LIVN]ByMarco Dolci leads the Cardiopulmonary business unit for LivaNova. He joined the company in 2017. Dolci has more than 30 years of experience working in the healthcare and medical device industries.The EssenzTM Perfusion System is not available for sale. It is currently in development and is intended to be approved by relevant authorities Information around the Perfusion System is only available in selected geographies.In My Opinion
< Page 7 | Page 9 >